Logo image
Addressing the global challenges of COVID-19 and other pulmonary diseases with microfluidic technology
Journal article   Open access   Peer reviewed

Addressing the global challenges of COVID-19 and other pulmonary diseases with microfluidic technology

Yuliang Xie, Ryan Becker, Michael Scott, Kayla Bean and Tony Jun Huang
Engineering (Beijing, China), Vol.24, pp.17-20
05/2023
DOI: 10.1016/j.eng.2022.01.003
PMCID: PMC8791846
PMID: 35103108
url
https://doi.org/10.1016/j.eng.2022.01.003View
Published (Version of record) Open Access

Abstract

COVID-19, an infectious pulmonary disease caused by the SARS-CoV-2 virus, has profoundly impacted the world, motivating researchers across a broad spectrum of academic disciplines to gain a deeper understanding and develop effective therapies to this disease. This article presents an engineering perspective on how microfluidic technologies may address some of the challenges presented by COVID-19 and other pulmonary diseases. In particular, this article highlights urgent needs in pulmonary medicine, with an emphasis on technological innovations in the microfluidic manipulation of particles and fluids, and how these innovations may contribute to the study, diagnosis, and therapy of pulmonary diseases.
Pulmonary Diseases COVID-19 Diagnostics Microfluidic technology Therapeutics

Details

Metrics

17 Record Views
Logo image